EN
HI
Summary
As of 25 Oct, 2026, Ind-Swift Laboratories stock price is ₹327.45. During the trading session, the stock has moved between an intraday low of ₹321.15 and an intraday high of ₹348.70. Over the last 52 weeks, Ind-Swift Laboratories has traded between ₹87.15 and ₹424.75.
The stock has recorded a trading volume of 6,58,248 shares,. Its Average Traded Price (ATP) is ₹330.49, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 710 @ ₹327.45.
Ind-Swift Laboratories has an upper circuit limit of ₹392.90 and a lower circuit limit of ₹262.00. The total value traded stands at ₹21.75 CR, and the delivery percentage for the day is 44.36%.
The stock is currently traded with a market lot size of 1. Ind-Swift Laboratories also offers a dividend yield of 0%.
Ind-Swift Laboratories Share Price Chart
Ind-Swift Laboratories Share Key Metrics
Volume
6.58 L
Market Cap
2847.56 CR
LTQ@LTP
710@327.45
ATP
330.49
Var Margin
100 %
Circuit Range
262-392.9
Delivery %
44.36 %
Value
21.75 CR
ASM/GSM
No
Market Lot
1
Ind-Swift Laboratories Fundamentals
P/E Ratio
50.53
P/B Ratio
2.02
Div. Yield
0
Sector P/E
37.75
Sector P/B
3.16
Sec. Div. Yield
0.54
Ind-Swift Laboratories Resistance and Support
Pivot 343.97
Resistance
First Resistance
351.94
Second Resistance
358.52
Third Resistance
366.49
Support
First Support
337.39
Second Support
329.42
Third Support
322.84
Ind-Swift Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 23 2026 | 345 | 327.45 | -5.18% | 348.7 | 321.15 |
| Thu Oct 22 2026 | 337 | 345.35 | 0.83% | 350.54 | 336 |
| Wed Oct 21 2026 | 353 | 342.5 | -2.67% | 366 | 336.79 |
Ind-Swift Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results |
| 2026-08-10 | Quarterly Results |
| 2026-07-10 | To consider issue of Warrants |
| 2026-05-28 | Audited Results |
| 2026-01-31 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-13 | Quarterly Results |
| 2025-02-12 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Ind-Swift Laboratories News
Ind-Swift Laboratories Ltd - 532305 - Board Meeting Intimation for Meeting To Be Held On October 29, 2026.
Ind Swift Laboratories board of directors will meet on 29 October 2026. The agenda includes approval of the financial results for the quarter and half-year ended 30 September 2026.
Oct 15 2026 18:35:33
Ind-Swift Laboratories Ltd - 532305 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Ind Swift promoter entity Essix Biosciences acquired 14 lakh equity shares upon conversion of warrants on October 8, 2026. The total promoter and promoter group holding in the company has increased from 42.93% to 43.84%. 56 lakh warrants remain pending for conversion.
Oct 12 2026 17:38:01
Read More
Ind-Swift Laboratories Management
| Name | Position |
|---|---|
| Pardeep Verma | VP-Corp. Affairs, Company Secretary & Compliance Officer |
| Navrattan Munjal | Chairman & Managing Director |
Ind-Swift Laboratories Similar Stocks
Kwality Pharmaceuticals Ltd.
3528.40
-89.90 (2.48%)
Aarti Drugs Ltd.
374.90
-5.15 (1.36%)
Unichem Laboratories Ltd.
472.95
-14.80 (3.03%)
Solara Active Pharma Sciences Ltd.
611.55
-7.50 (1.21%)
Shukra Medtech Ltd.
64.46
1.93 (3.09%)
Advanced Enzyme Technologies Ltd.
248.35
-10.50 (4.06%)
Hikal Ltd.
193.65
-9.53 (4.69%)
Dr Agarwals Eye Hospital Ltd.
5055.50
96.50 (1.95%)
Fredun Pharmaceuticals Ltd.
1368.40
-22.60 (1.62%)
Dishman Carbogen Amcis Ltd.
136.28
-3.74 (2.67%)
Ind-Swift Laboratories FAQs
The Buying Price of Ind-Swift Laboratories share is 327.45 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ind-Swift Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ind-Swift Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ind-Swift Laboratories shares is 50.53. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ind-Swift Laboratories shares is 2.02. Useful to assess the stock's value relative to its book value.
To assess Ind-Swift Laboratories’s valuation compare Sector P/E, P/B which are 37.75 & 3.16 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ind-Swift Laboratories is 2847.56 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ind-Swift Laboratories share price is 424.75 & 87.15. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ind-Swift Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in INDSWFTLAB
Or Download Choice FinX App
Invest in INDSWFTLAB
